ArticleCancer biology & therapy2017

The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer.

Abigail Winder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.